Thirteen years old
Release time:
2020-07-22
13 years old
13 years old, I have a piece of my own sky.
I am no longer naive, everything has changed, hobbies have changed, personality has changed, thoughts have changed, and views on things have changed.
Thirteen years old, I began to love the quiet. I will not chase after the small fart children in the community any more. I always like to fall on the sofa stupidly and lazily and look around in a daze. I like to read articles about people's narration and taste their joys and sorrows. I like to throw myself on a soft quilt and sleep beautifully. When I wake up, I will forget anything unpleasant and uncomfortable.
Thirteen years old, I like to look up at the stars.
I like to lie alone on the grass, looking at those places that are out of reach, like to watch the stars move, in the summer night sky in the countryside, looking for the brightest Taurus of my own. I always felt like I was in a dream, the universe and the stars hugging me. I like to look up at the stars alone, enjoy the beautiful Milky Way, looking for the brightest star in the night sky.
At the age of thirteen, my temper has become a bit bad, like a mine, which will explode at the first touch. If anyone disturbs my neatness and touches my desk, I will throw my pen at him with a rough nose, and stand up and look down at him with a face of "ruthless " but "righteous " . When they saw that the situation was not good, they slowly slipped away.
Thirteen years old, I have many friends. Turn on your phone and you won't always play those retarded games. I have my own WeChat. I like to talk with my friends, put out all my news, listen to their opinions and share happiness together.
Thirteen years old, my sky is very independent, every night before going to bed, I will write down the events of the day in my diary. There, I can speak freely, I can be unconstrained, I don't have to be as clear as a composition, and I will record whatever I think as long as it is meaningful. Like Xiao Hong's "Remembering Mr. Lu Xun", no one knows except myself. When I grow up and open it, it will be a good memory.
I am no longer a child at the age of 13. I have a lot of joy and worries, but whatever it is, I just need to be the best of myself.
Thirteen-year-old I finally realized the complexity. The taste of teenagers, their own taste. (Ying Chen Rui) (The author is the son of Fang Hongying, a manufacturer of Jianfeng Pharmaceuticals)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page